Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis.


Pre-clinical studies indicate that pharmacologic agents can augment fracture union. If these pharmacologic approaches could be translated into clinical benefit and offered to patients with osteoporosis or patients with other risks for impaired fracture union (e.g. in subjects with large defects or open fractures with high complication rate), they could… (More)
DOI: 10.1016/j.bone.2008.04.017